ADMA Biologics, Inc. (ADMA)

NASDAQ: ADMA · Real-Time Price · USD

14.93

+0.06 (0.40%)

Mar 19, 2026, 3:43 PM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
ADMA Biomanufacturing	493.00M	415.81M	249.74M	144.07M	74.94M
ADMA Biomanufacturing Growth	18.56%	66.50%	73.34%	92.26%	104.33%
Plasma Collection Centers	17.03M	10.51M	8.33M	9.87M	5.86M
Plasma Collection Centers Growth	62.11%	26.05%	-15.54%	68.26%	8.52%
Unallocated License Revenues	143.00K	143.00K	143.00K	143.00K	-
Unallocated License Revenues Growth	0%	0%	0%	-	-
Corporate	-	-	-	-	143.00K
Corporate Growth	-	-	-	-	0.12%
Total	510.17M	426.45M	258.22M	154.08M	80.94M
Total Growth	19.63%	65.15%	67.59%	90.36%	91.72%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	504.07M	410.15M	244.88M	146.43M	70.63M
United States Growth	22.90%	67.49%	67.24%	107.33%	93.22%
International	6.11M	16.31M	13.33M	7.65M	10.32M
International Growth	-62.55%	22.29%	74.23%	-25.82%	82.04%
Total	510.17M	426.45M	258.22M	154.08M	80.94M
Total Growth	19.63%	65.15%	67.59%	90.36%	91.72%

Source: S&P Global Market Intelligence.